STOCK TITAN

[Form 4] AstroNova, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Yvonne Schlaeppi, a director of AstroNova, Inc. (ALOT), received a restricted stock award of 3,196 shares on 08/28/2025 under the Amended and Restated Non-Employee Director Annual Compensation Program. The shares were granted at a price of $0 and, after the award, the reporting person beneficially owned 44,426.954 shares. The Form 4 was signed by Daniel Clevenger by power of attorney on 09/02/2025. The filing documents a routine, non-derivative equity grant to a director as part of standard board compensation.

Yvonne Schlaeppi, consigliera di AstroNova, Inc. (ALOT), ha ricevuto il 28/08/2025 un premio in azioni vincolate pari a 3.196 azioni nell'ambito dell'Amended and Restated Non-Employee Director Annual Compensation Program. Le azioni sono state assegnate a prezzo $0 e, a seguito del premio, la persona segnalante deteneva beneficiariamente 44.426,954 azioni. Il Modulo 4 è stato firmato per procura da Daniel Clevenger il 02/09/2025. La comunicazione documenta una consueta assegnazione azionaria non derivativa a un membro del consiglio come parte della normale retribuzione del board.

Yvonne Schlaeppi, directora de AstroNova, Inc. (ALOT), recibió el 28/08/2025 una adjudicación de acciones restringidas por 3.196 títulos en virtud del Amended and Restated Non-Employee Director Annual Compensation Program. Las acciones se concedieron a un precio de $0 y, tras la adjudicación, la persona informante poseía beneficiariamente 44.426,954 acciones. El Formulario 4 fue firmado por poder por Daniel Clevenger el 02/09/2025. La presentación documenta una concesión rutinaria de capital no derivado a una directora como parte de la compensación habitual del consejo.

Yvonne Schlaeppi는 AstroNova, Inc.(ALOT)의 이사로서 2025년 8월 28일 Amended and Restated Non-Employee Director Annual Compensation Program에 따라 3,196주의 제한주를 수여받았습니다. 해당 주식은 $0의 가격으로 부여되었고, 수여 후 보고 대상자는 44,426.954주를 실질적으로 보유하게 되었습니다. Form 4는 2025년 9월 2일 Daniel Clevenger가 위임장으로 서명했습니다. 이 제출서는 이사회 보상 일환으로 이사에게 정기적으로 지급되는 비파생 주식 부여를 문서화한 것입니다.

Yvonne Schlaeppi, administratrice d'AstroNova, Inc. (ALOT), a reçu le 28/08/2025 une attribution d'actions restreintes de 3 196 actions dans le cadre de l'Amended and Restated Non-Employee Director Annual Compensation Program. Les actions ont été accordées au prix de 0 $ et, après l'attribution, la personne déclarante détenait bénéficiairement 44 426,954 actions. Le formulaire 4 a été signé par procuration par Daniel Clevenger le 02/09/2025. Le dépôt documente une attribution d'actions non dérivée et routinière à une administratrice dans le cadre de la rémunération habituelle du conseil.

Yvonne Schlaeppi, Direktorin von AstroNova, Inc. (ALOT), erhielt am 28.08.2025 eine Zuteilung von 3.196 eingeschränkten Aktien im Rahmen des Amended and Restated Non-Employee Director Annual Compensation Program. Die Aktien wurden zum Preis von $0 gewährt und nach der Zuteilung hielt die meldende Person wirtschaftlich 44.426,954 Aktien. Das Formular 4 wurde am 02.09.2025 von Daniel Clevenger per Vollmacht unterzeichnet. Die Meldung dokumentiert eine routinemäßige, nicht-derivative Aktienzuteilung an ein Vorstandsmitglied als Teil der üblichen Vergütung des Boards.

Positive
  • Restricted stock award aligns director compensation with shareholder interests
Negative
  • None.

Insights

TL;DR: Routine director equity grant to align interests; no unusual terms disclosed.

The Form 4 shows a standard restricted stock award to a non-employee director under the company's established director compensation program. The grant of 3,196 shares at $0 is reported as a non-derivative acquisition and results in total beneficial ownership of 44,426.954 shares. There is no indication of accompanying unusual vesting, acceleration, or performance-based conditions in the provided text; the filer notes the award arises from the Amended and Restated Non-Employee Director Annual Compensation Program. For governance review, this appears to be a routine compensation action rather than a material corporate event.

TL;DR: Small, routine equity issuance; negligible market impact based on disclosed amounts.

The transaction is a non-derivative issuance of 3,196 restricted shares to a director, recorded at $0, increasing the director's beneficial stake to 44,426.954 shares. The filing contains no details on vesting schedule or acceleration rights, and no cash consideration was reported. Given the size of the award in absolute terms and absence of additional transactional detail, this disclosure is unlikely to be material to the company's overall capitalization or near-term financials.

Yvonne Schlaeppi, consigliera di AstroNova, Inc. (ALOT), ha ricevuto il 28/08/2025 un premio in azioni vincolate pari a 3.196 azioni nell'ambito dell'Amended and Restated Non-Employee Director Annual Compensation Program. Le azioni sono state assegnate a prezzo $0 e, a seguito del premio, la persona segnalante deteneva beneficiariamente 44.426,954 azioni. Il Modulo 4 è stato firmato per procura da Daniel Clevenger il 02/09/2025. La comunicazione documenta una consueta assegnazione azionaria non derivativa a un membro del consiglio come parte della normale retribuzione del board.

Yvonne Schlaeppi, directora de AstroNova, Inc. (ALOT), recibió el 28/08/2025 una adjudicación de acciones restringidas por 3.196 títulos en virtud del Amended and Restated Non-Employee Director Annual Compensation Program. Las acciones se concedieron a un precio de $0 y, tras la adjudicación, la persona informante poseía beneficiariamente 44.426,954 acciones. El Formulario 4 fue firmado por poder por Daniel Clevenger el 02/09/2025. La presentación documenta una concesión rutinaria de capital no derivado a una directora como parte de la compensación habitual del consejo.

Yvonne Schlaeppi는 AstroNova, Inc.(ALOT)의 이사로서 2025년 8월 28일 Amended and Restated Non-Employee Director Annual Compensation Program에 따라 3,196주의 제한주를 수여받았습니다. 해당 주식은 $0의 가격으로 부여되었고, 수여 후 보고 대상자는 44,426.954주를 실질적으로 보유하게 되었습니다. Form 4는 2025년 9월 2일 Daniel Clevenger가 위임장으로 서명했습니다. 이 제출서는 이사회 보상 일환으로 이사에게 정기적으로 지급되는 비파생 주식 부여를 문서화한 것입니다.

Yvonne Schlaeppi, administratrice d'AstroNova, Inc. (ALOT), a reçu le 28/08/2025 une attribution d'actions restreintes de 3 196 actions dans le cadre de l'Amended and Restated Non-Employee Director Annual Compensation Program. Les actions ont été accordées au prix de 0 $ et, après l'attribution, la personne déclarante détenait bénéficiairement 44 426,954 actions. Le formulaire 4 a été signé par procuration par Daniel Clevenger le 02/09/2025. Le dépôt documente une attribution d'actions non dérivée et routinière à une administratrice dans le cadre de la rémunération habituelle du conseil.

Yvonne Schlaeppi, Direktorin von AstroNova, Inc. (ALOT), erhielt am 28.08.2025 eine Zuteilung von 3.196 eingeschränkten Aktien im Rahmen des Amended and Restated Non-Employee Director Annual Compensation Program. Die Aktien wurden zum Preis von $0 gewährt und nach der Zuteilung hielt die meldende Person wirtschaftlich 44.426,954 Aktien. Das Formular 4 wurde am 02.09.2025 von Daniel Clevenger per Vollmacht unterzeichnet. Die Meldung dokumentiert eine routinemäßige, nicht-derivative Aktienzuteilung an ein Vorstandsmitglied als Teil der üblichen Vergütung des Boards.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schlaeppi Yvonne

(Last) (First) (Middle)
C/O ASTRONOVA, INC.
600 EAST GREENWICH AVENUE

(Street)
WEST WARWICK RI 02893

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AstroNova, Inc. [ ALOT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/28/2025 A(1) 3,196 A $0 44,426.954 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted stock award made to the reporting person pursuant to the Amended and Restated Non-Employee Director Annual Compensation Program.
/s/ Daniel Clevenger, by Power of Attorney 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the AstroNova (ALOT) Form 4 report for Yvonne Schlaeppi?

The Form 4 reports a restricted stock award of 3,196 shares to director Yvonne Schlaeppi on 08/28/2025 under the company's director compensation program.

How many shares does Yvonne Schlaeppi beneficially own after the transaction?

Following the reported transaction, the filing shows beneficial ownership of 44,426.954 shares.

What price was reported for the shares in the AstroNova Form 4?

The shares were reported with a transaction price of $0, reflecting a restricted stock award.

Who signed the Form 4 for Yvonne Schlaeppi and when was it signed?

The Form 4 was signed by /s/ Daniel Clevenger, by Power of Attorney on 09/02/2025.

Under what program was the restricted stock award issued?

The filing states the award was made pursuant to the Amended and Restated Non-Employee Director Annual Compensation Program.
Astronova

NASDAQ:ALOT

ALOT Rankings

ALOT Latest News

ALOT Latest SEC Filings

ALOT Stock Data

87.43M
6.56M
13.18%
52.24%
0.13%
Computer Hardware
Computer Peripheral Equipment, Nec
Link
United States
WEST WARWICK